Mylan must hand over authorised generic docs ahead of injunction hearing

Intellectual Property 2019-03-25 8:29 pm By Miklos Bolza | Sydney

Pharmaceutical giant Mylan has been ordered to hand over documents relating to its proposed launch of a generic version of its cholesterol drug Lipidil to rival Sun Pharma in advance of a hearing on Mylan’s request for an order blocking Sun from launching its own generic version of the drug.